Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
Metabolomics: Technologies and Global Markets
... 32 data tables and 39 additional tables An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms Analysis of global market trends, featuring ... Read More
-
Healthcare BPO Market by Outsourcing Models, Provider (Patient Care, RCM), Payer (Claims Management, Billing & Accounts), Life Science (R&D, Manufacturing, Sales & Marketing (Analytics, Research)), & Region (Source, Destination) - Global Forecast to 2029
... global healthcare BPO market is projected to reach USD 626.6 billion by 2029 from USD 395.3 billion in 2024, at a CAGR of 9.7% from 2024 to 2029. The growth of the healthcare BPO market ... Read More
-
Global Neuroendocrine Tumors (NETs) Market (2024 Edition): Analysis By Therapy (Somatostatin Analogs (SSAs), Targeted Therapy, Others), By Route of Administration, By Indication, By End User, By Region: Market Insights and Forecast (2020-2030)
... Analytics has released a research report titled “Global Neuroendocrine Tumors (NETs) Market (2024 Edition)” which provides a complete analysis of the Global Neuroendocrine Tumors (NETs) industry in terms of market segmentation by Therapy (Somatostatin Analogs ... Read More
-
Global Injectable Cytotoxic Drugs Market (2024 Edition): Market Size, Trends, Opportunities and Forecast By Drug Class (Plant Alkaloids, Alkylating Drugs, Antimetabolites, Cytotoxic Antibodies and Other Drug Classes), Application, Distribution Channel, Region, By Country: 2020-2030
... A report published by Azoth Analytics highlights different factors and opportunities prevailing in the “Global Injectable Cytotoxic Drugs Market (2024 Edition)”. According to the report, Global Injectable Cytotoxic Drugs Market valued at USD 18.3 Billion ... Read More
-
Global Recombinant Proteins Market
... for 2029, the market’s competitive environment and companies’ pipeline activities. The report delivers market estimates and forecasts for recombinant proteins categorized according to product type, host cell type, application, and region. Based on product type ... Read More
-
Global Rare Disease Treatment Competitive Landscape Professional Research Report 2024
... as orphan diseases, affect a relatively small number of people in the population. Due to their rarity, developing treatments for these conditions can pose significant challenges, including limited research, lack of available therapies, and difficulties ... Read More
-
Stem Cell Assays Market Assessment, By Assay Type [Viability/Cytotoxicity Assays, Isolation and Purification Assays, Cell Identification Assays, Proliferation Assays, Differentiation Assays, Function Assays, Apoptosis Assays], By Cell Type [Adult Stem Cells, Human Embryonic Stem Cells], By Product Type [Instruments, Reagents and Kits], By Application Type [Regenerative Medicine and Therapy Development, Drug Discovery and Development, Clinical Research], By End-user [Biopharmaceutical and Biotechnology Companies, Academic Institutes and Research Facilities, Others], By Region, Opportunities and Forecast, 2017-2031F
... By Product Type [Instruments, Reagents and Kits], By Application Type [Regenerative Medicine and Therapy Development, Drug Discovery and Development, Clinical Research], By End-user [Biopharmaceutical and Biotechnology Companies, Academic Institutes and Research Facilities, Others], By Region, ... Read More
-
Computational Biology Market by Services (Contract, In-house), Application (Cellular Biological Simulation, Clinical Trials, Drug Discovery & Disease Modelling), End-Use - Global Forecast 2024-2030
... 2023 and expected to reach USD 7.42 billion in 2024, at a CAGR 18.91% to reach USD 21.01 billion by 2030. Computational biology is an interdisciplinary domain that applies techniques from computer science, applied mathematics, ... Read More
-
Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Global Forecast 2024-2030
... 5.05 billion in 2023 and expected to reach USD 5.80 billion in 2024, at a CAGR 14.51% to reach USD 13.04 billion by 2030. The recombinant proteins are created by inserting a modified gene into ... Read More
-
3D Cell Culture Market by Product (3D Bio Printing, Magnetic Levitation, Microfluidics-based 3D Cell Culture), Application (Cancer, Drug Discovery, Stem Cell Research), End-User - Global Forecast 2024-2030
... at USD 1.90 billion in 2023 and expected to reach USD 2.04 billion in 2024, at a CAGR 7.63% to reach USD 3.19 billion by 2030. 3D cell culture refers to the practice of growing ... Read More
-
Research Antibodies Market by Indication (Immunology, Infectious Diseases, Neurobiology), Operation (Drug Development, Genomics, Proteomics), Product, Source, Technology, Type, End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 6.79 billion in 2024, at a CAGR 8.43% to reach USD 11.05 billion by 2030. The market for research antibodies refers to the global industry that revolves around ... Read More
-
Pharmaceutical Manufacturing Market by Formulation (Capsules, Injectable, Powders), Drug Development Type (In-House, Outsource), Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Global Forecast 2024-2030
... USD 620.68 billion in 2023 and expected to reach USD 672.44 billion in 2024, at a CAGR 8.66% to reach USD 1,110.17 billion by 2030. Pharmaceutical manufacturing comprises research, development, production, marketing, and distribution of ... Read More
-
Biosimulation Market by Offering (Services, Software), Delivery Model (Ownership Models, Subscription Models), End-User, Application - Global Forecast 2024-2030
... 4.40 billion in 2024, at a CAGR 14.55% to reach USD 9.87 billion by 2030. Biosimulation combines mathematics, biology, and computer programming to create simulations to test hypotheses, predict outcomes, and explore new possibilities in ... Read More
-
RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Market Growth & Trends The global RNAi technology market size is anticipated to reach USD 6.65 billion by 2030 and is growing at a CAGR of 14.6% from 2024 to 2030, according to a new ... Read More
-
Drug Discovery Market by Drug Type (Biologic Drugs, Small Molecule Drugs), Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Therapeutic Area, End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 71.12 billion in 2024, at a CAGR 14.10% to reach USD 157.13 billion by 2030. Drug discovery is a multifaceted and intricate process that encompasses the identification of ... Read More
-
Organoids Global Market Opportunities And Strategies To 2033 Including: 1) By Product: Hepatic Organoids; Colorectal Organoids; Intestinal Organoids 2) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine 3) By End-Use Industries: Hospitals And Diagnostic Centers; Biopharmaceutical Companies; Academics And Research Institutes; Contract Research Organizations 4) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells Covering: Thermo Fisher Scientific Inc.; Carl Zeiss AG; Corning Incorporated; Lonza Group Ltd.; STEMCELL Technologies Inc.
... from the COVID-19 shut down. Reasons to Purchase • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. • Understand how the market is being affected by ... Read More
-
Global Messenger RNA – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Global Messenger RNA market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Global Messenger RNA market report provides current ... Read More
-
Small Molecule API Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 2.53 billion in 2023, and the market is now projected to grow from USD 2.76 billion in 2024 to USD 5.44 billion by 2032, exhibiting a CAGR of 8.9% during the forecast ... Read More
-
Global mRNA Raw Enzyme Market Report, History and Forecast 2019-2030
... US$ 1,731.22 million by 2030, growing at a CAGR of 1.42% during the forecast period 2024-2030. North American market for mRNA Raw Enzyme was valued at $ 640.10 million in 2023 and will reach $ ... Read More
-
Liver Disease Therapeutic Market Report by Therapy Type (Anti-Rejection Drugs/Immunosuppressants, Chemotherapy Drugs, Targeted therapy, Vaccines, Immunoglobulins, Corticosteroids, and Anti-Viral Drugs) Disease Type (Non-alcoholic Fatty Liver Disease (NAFLD), Viral Hepatitis (B, C, D), Alcoholic Liver Disease (ALD), and Autoimmune Liver Disease (ALD)) End Users (Hospitals, Laboratories, and Others) Regions and Company Analysis 2024-2032
... (ALD), and Autoimmune Liver Disease (ALD)) End Users (Hospitals, Laboratories, and Others) Regions and Company Analysis 2024-2032 The market for Liver Disease Therapeutics is predicted to reach US$ 28.98 billion in 2032, increasing at a ... Read More
-
Organ-on-Chip Market - A Global and Regional Analysis: Focus on Offering, Organ Type, Application, End User, and Country - Analysis and Forecast, 2024-2033
... reach $3,596.3 million by 2033 from $109.9 million in 2023, growing at a CAGR of 42.09% during the forecast period 2024-2033. The key factors driving the growth of the global organ-on-chip market include continuous technological ... Read More
-
Global Drug Discovery Informatics Market 2024-2028
... drug discovery informatics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Thematic Intelligence: Rare Disease
... at accelerating progress in this field. Key drivers of innovation in the rare disease space include advances in genomics, molecular diagnostics, precision medicine, and therapeutic development, which hold promise for personalized approaches to diagnosis and ... Read More
-
Rare Disease Treatment Market – By Drug Type (Biologics, Non-biologics), Therapeutic Area (Cancer, Respiratory Disorder, Cardiovascular Disorder), Patient (Adult, Pediatric), Route of Administration (Oral, Injectable) – Global Forecast (2024 2032)
... Market will reach a 9% CAGR from 2024 to 2032, attributed to advancements in medical research coupled with robust biopharmaceutical investments. Breakthroughs in gene therapies, precision medicine, and targeted treatments are reshaping therapeutic approaches. Moreover, ... Read More
-
Global 3D Bioprinting in Medical Market Size study, by Products and Solutions (Bioprinters, Consumables and accessories, Software and services) by Technology (Extrusion based bioprinting, Inkjet based bioprinting, Laser assisted bioprinting, Others), by Application (Tissue engineering and regenerative medicine, Drug discovery and development, Others), by End User (Biotechnology and pharmaceutical companies, Academic and research institutes, Others) and Regional Forecasts 2022-2032
... and regenerative medicine, Drug discovery and development, Others), by End User (Biotechnology and pharmaceutical companies, Academic and research institutes, Others) and Regional Forecasts 2022-2032 Global 3D Bioprinting in Medical Market is valued approximately at USD ... Read More
Research Assistance
